Rabbit Recombinant Monoclonal FNIP1 antibody. Suitable for WB and reacts with Mouse, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | |
---|---|
Human | Tested |
Mouse | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes - |
Species Human | Dilution info 1/1000 | Notes - |
Select an associated product type
Binding partner of the GTPase-activating protein FLCN: involved in the cellular response to amino acid availability by regulating the non-canonical mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3 (PubMed:23582324). Required to promote FLCN recruitment to lysosomes and interaction with Rag GTPases, leading to activation of the non-canonical mTORC1 signaling (By similarity). In low-amino acid conditions, component of the lysosomal folliculin complex (LFC) on the membrane of lysosomes, which inhibits the GTPase-activating activity of FLCN, thereby inactivating mTORC1 and promoting nuclear translocation of TFEB and TFE3 (By similarity). Upon amino acid restimulation, disassembly of the LFC complex liberates the GTPase-activating activity of FLCN, leading to activation of mTORC1 and subsequent inactivation of TFEB and TFE3 (By similarity). Together with FLCN, regulates autophagy: following phosphorylation by ULK1, interacts with GABARAP and promotes autophagy (By similarity). In addition to its role in mTORC1 signaling, also acts as a co-chaperone of HSP90AA1/Hsp90: following gradual phosphorylation by CK2, inhibits the ATPase activity of HSP90AA1/Hsp90, leading to activate both kinase and non-kinase client proteins of HSP90AA1/Hsp90 (By similarity). Acts as a scaffold to load client protein FLCN onto HSP90AA1/Hsp90 (By similarity). Competes with the activating co-chaperone AHSA1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (By similarity). Also acts as a core component of the reductive stress response by inhibiting activation of mitochondria in normal conditions: in response to reductive stress, the conserved Cys degron is reduced, leading to recognition and polyubiquitylation by the CRL2(FEM1B) complex, followed by proteasomal (PubMed:32941802). Required for B-cell development (PubMed:22709692, PubMed:27303042).
Kiaa1961, Fnip1, Folliculin-interacting protein 1
Rabbit Recombinant Monoclonal FNIP1 antibody. Suitable for WB and reacts with Mouse, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Expression levels of the target protein vary with sample type and some optimisation may be required.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and dilution buffer: 5% NFDM/TBST.
Exposure times.
Lane 1: 1 minute; Lane 2: 70 seconds.
The molecular mass observed is consistent with what has been described in the literature (PMID: 17028174). The specific Fnip1 band is around 150 kDa; the other bands are non-specific. Lane 2 was developed using a high sensitivity ECL substrate. Expression levels of the target protein vary with sample type and some optimisation may be required
All lanes: Western blot - Anti-FNIP1 antibody [EPR20832] (ab215725) at 1/1000 dilution
Lane 1: Mouse testis lysate at 20 µg
Lane 2: L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg
Lane 1: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Lane 2: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 131 kDa
Observed band size: 150 kDa
Blocking buffer: 7% non-fat milk diluted in TBS-T.
Dilution buffer: 1% BSA diluted in TBS.
The molecular mass observed is consistent with what has been described in the literature (PMID: 17028174).
The image was kindly provided by our collaborator Dr. Zhenji Gan, Nanjing University.
The specific Fnip1 band is around 150 kDa; the other bands are non-specific. Expression levels of the target protein vary with sample type and some optimisation may be required.
All lanes: Western blot - Anti-FNIP1 antibody [EPR20832] (ab215725) at 1/500 dilution
Lane 1: Mouse muscle lysate at 75 µg
Lane 2: FNIP1 knockout mouse muscle lysate at 75 µg
All lanes: Peroxidase-AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/7500 dilution
Predicted band size: 131 kDa
Observed band size: 150 kDa
Exposure time: 15min
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com